ADAMTS13 activity is known to be a prognostic marker not only in the acute presentation of TTP but also in remission, with persistent undetectable levels in recovering patients associated with an increased risk of disease exacerbation or recurrence [20]. The gene discussed is ADAMTS13; the disease is thrombotic thrombocytopenic purpura.